Summary by Futu AI
On June 19, 2024, China Resources Pharmaceutical Group Limited (CR Pharma, Stock Code: 3320) submitted the next day disclosure form and disclosed its shareholding changes. According to the Listing Rules of The Hong Kong Stock Exchange Limited (HKEX), the company has not issued or repurchased any shares, and the number of shares remained at 575,653,415. However, the company conducted several share repurchases from May 31, 2024 to June 19, 2024, with a total of 2,740,000 shares repurchased at a repurchase price ranging from HKD 5.36 to HKD 6.99. The latest share repurchase occurred on June 19, 2024, with 700,000 shares repurchased at a price ranging from HKD 5.47 to HKD 5.76 and a total payment of HKD 3,979,995. The company confirms that all share repurchases are conducted in accordance with regulations and there are no significant changes. In addition, the company will not issue any new shares or sell or transfer any treasury stocks within 30 days after the share repurchase, i.e. as of July 19, 2024.